1. Home
  2. FGEN vs NCEW Comparison

FGEN vs NCEW Comparison

Compare FGEN & NCEW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FGEN
  • NCEW
  • Stock Information
  • Founded
  • FGEN 1993
  • NCEW 2002
  • Country
  • FGEN United States
  • NCEW Hong Kong
  • Employees
  • FGEN N/A
  • NCEW N/A
  • Industry
  • FGEN Biotechnology: Pharmaceutical Preparations
  • NCEW
  • Sector
  • FGEN Health Care
  • NCEW
  • Exchange
  • FGEN Nasdaq
  • NCEW NYSE
  • Market Cap
  • FGEN 33.5M
  • NCEW 25.4M
  • IPO Year
  • FGEN 2014
  • NCEW 2024
  • Fundamental
  • Price
  • FGEN $7.03
  • NCEW $0.76
  • Analyst Decision
  • FGEN Strong Buy
  • NCEW
  • Analyst Count
  • FGEN 1
  • NCEW 0
  • Target Price
  • FGEN $250.00
  • NCEW N/A
  • AVG Volume (30 Days)
  • FGEN 43.0K
  • NCEW 93.8K
  • Earning Date
  • FGEN 08-12-2025
  • NCEW 08-15-2025
  • Dividend Yield
  • FGEN N/A
  • NCEW N/A
  • EPS Growth
  • FGEN N/A
  • NCEW N/A
  • EPS
  • FGEN N/A
  • NCEW 0.01
  • Revenue
  • FGEN $6,996,000.00
  • NCEW $52,176,109.00
  • Revenue This Year
  • FGEN N/A
  • NCEW N/A
  • Revenue Next Year
  • FGEN N/A
  • NCEW N/A
  • P/E Ratio
  • FGEN N/A
  • NCEW $70.26
  • Revenue Growth
  • FGEN N/A
  • NCEW 44.64
  • 52 Week Low
  • FGEN $4.50
  • NCEW $0.75
  • 52 Week High
  • FGEN $29.00
  • NCEW $4.15
  • Technical
  • Relative Strength Index (RSI)
  • FGEN 50.17
  • NCEW N/A
  • Support Level
  • FGEN $7.04
  • NCEW N/A
  • Resistance Level
  • FGEN $7.56
  • NCEW N/A
  • Average True Range (ATR)
  • FGEN 0.49
  • NCEW 0.00
  • MACD
  • FGEN -0.00
  • NCEW 0.00
  • Stochastic Oscillator
  • FGEN 12.53
  • NCEW 0.00

About FGEN FibroGen Inc

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.

About NCEW NEW CENTURY LOGISTICS (BVI) LIMITED

New Century Logistics (BVI) Ltd is a well-established freight forwarding service provider based in Hong Kong. The company provides air and ocean export and import freight forwarding services ranging from the sale of cargo space, cargo pick up, off-airport air cargo security screening, palletization, preparation of shipping documentation, and arrangement of customs clearance to cargo handling at ports. It provides a full range of logistics services by providing to its customers with a robust international network that strategically supports the movement of its customers' goods. Includes various logistic like New Century Logistics Company Limited, GLF Cargo Services Limited, Win-Tec Transportation Company Limited.

Share on Social Networks: